Open Surgery Clinical Trial
— PRIMOOfficial title:
Post-Market, Non-Randomized, Multicentre PMCF Study to Monitor the Safety and Performance of Symani System in Microsurgical Reconstructive Procedures in a Real Life Setting
Post Market Clinical Follow up Study aimed to collect clinical data on safety and efficacy of Robotically Assisted System called Symani to perform microsurgery techniques such as anastomosis, suturing and ligation for open surgery procedures on small anatomical structures such as blood vessels, lymphatic ducts and nerves.
Status | Recruiting |
Enrollment | 420 |
Est. completion date | December 31, 2026 |
Est. primary completion date | April 1, 2026 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 100 Years |
Eligibility | Inclusion Criteria: - Male and female patients aged >18 - Patients who need a reconstructive procedure and a microsurgical reconstruction is deemed the best option by the plastic, orthopedic or other surgeon in response to a post-oncological, post-traumatic or congenital tissue defect or to treat lymphedema. - Patients who have been selected by the Clinical Registry Manager at the Clinical Center as appropriate candidates for treatment with RASM in accordance with the Instruction For Use (IFU). - Subjects who fit the criteria to perform surgery requiring reconstructions using free flaps, replantations or lymphatic reconstructions. - Subjects who agree to have the surgery and the anesthesia. - Subjects who voluntarily decide to participate in this registry with the surgery performed with the aid of the RASM Surgical System and sign the Informed Consent Form Exclusion Criteria: - Subjects who have bleeding or coagulation disorders in the past or present. - Any criteria that preclude prolonged anesthesia. - History of anaphylaxis or severe complicated allergy symptoms. - Clinically significant cardiovascular, digestive, respiratory, endocrine, or central nervous system disorders or previous mental disorders that may significantly affect the data collection or the ability to comply with the protocol. - Evidence or history of autoimmune disease or compromised immune system. - Participation in another clinical trial within 4 weeks prior to participation in the registry. - Subjects belonging to vulnerable populations or ineligible to participate for other reasons by a Clinical Registry Manager at a Clinical Center. - Subjects with pacemaker |
Country | Name | City | State |
---|---|---|---|
Austria | LKH Salzburg, Universitätsklinik für Mund-, Kiefer- und Gesichtschirurgie | Salzburg | |
Belgium | Universitair Ziekenhuis Brussel | Brussel | |
Germany | Klinik für Mund-, Kiefer- und Gesichtschirurgie UKSH Kiel | Kiel | |
Germany | Fachklinik Hornheide | Münster | |
Italy | Istituto Ortopedico Rizzoli | Bologna | |
Italy | Azienda Ospedaliera Universitaria Careggi | Firenze | |
Spain | Hospital de la Santa Creu i Sant Pau | Barcelona | |
Switzerland | University Hospital Zurich | Zürich |
Lead Sponsor | Collaborator |
---|---|
MMI Spa |
Austria, Belgium, Germany, Italy, Spain, Switzerland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Procedure Robotic Success | Ability to complete the surgical task with Symani as intended by the surgeon | Procedure | |
Secondary | Anastomosis time | Time to execute each anastomosis | Procedure | |
Secondary | Intraoperative redo | Intraoperative need to repeat anastomosis | Procedure | |
Secondary | Postoperative redo | Postoperative need to repeat anastomosis | 7 days | |
Secondary | Complications | Major or minor complications | 30 days | |
Secondary | Free Flap/Replantation Failure | Failure of the free flap or replantation | 30 days | |
Secondary | Limb volume reduction (for lymphatic surgery) | Limb volume reduction | 24 weeks | |
Secondary | Warm ischemia time | Time for warm ischemia | Procedure |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT01596049 -
The Efficacy of a Self-fixating Mesh in Unilateral Open Inguinal Hernia Repair
|
N/A | |
Active, not recruiting |
NCT06219993 -
Robot-assisted Modified Kasai Portoenterostomy Versus Open Kasai Portoenterostomy for Biliary Atresia
|
||
Recruiting |
NCT05019404 -
Minimally Invasive Surgical Epilepsy Trial for Temporal Lobe Epilepsy
|
N/A |